Study on the Efficacy and Safety of Thermotherapy in the Treatment of Refractory Gout

NANot yet recruitingINTERVENTIONAL

Enrollment

128

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

November 30, 2026

Conditions

Refractory Gout

Interventions

OTHER

Hyperthermia combined with oral febuxostat.

Extracorporeal high-frequency hyperthermia combined with oral febuxostat

DRUG

Febuxostat

The control group subjects were administered oral febuxostat.

All Listed Sponsors

lead

The First Hospital of Jilin University

OTHER

NCT06653686 - Study on the Efficacy and Safety of Thermotherapy in the Treatment of Refractory Gout | Biotech Hunter | Biotech Hunter